Fudan-Zhangjiang invests RMB90m in structured deposits

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. has announced its entry into structured deposit product agreements with China Merchants Bank, involving a total investment of RMB90 million. The transactions involve two agreements: one directly with China Merchants Bank, and the other via its subsidiary, Taizhou Fudan-Zhangjiang. The funds are sourced from the Group's self-owned idle funds generated from daily operations. The expected annualized return rates range from 1.00% to 1.75%, linked to the performance of XAU/USD. While these transactions constitute disclosable transactions under Hong Kong's Listing Rules, they are exempt from shareholder approval. The company views this investment as a means to enhance its capital gains and safeguard liquidity, citing low risk factors compared to fixed-term deposits.